Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spacelabs Regs | LSE:SLAB | London | Ordinary Share | COMMON STOCK USD0.001 (REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 95.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2006 15:11 | Come up to the lab, and see what's on the SLAB! I see you shiver with antici- | arf dysg | |
02/11/2005 09:47 | Spacelabs?!? Well, I do like Kraftwerk. | ![]() wiganer | |
02/11/2005 09:44 | Deepak Chopra is a self made man, with a history of buiding succesful companies, i fully expect him to do so with this one also. | thedeal | |
31/10/2005 15:10 | 31 October 2005 SPACELABS HEALTHCARE, INC. ADMISSION TO AIM Spacelabs Healthcare, Inc. ('Spacelabs' or the 'Company') an international developer, manufacturer and distributor of medical equipment and services, was today admitted to the AIM Market ("AIM"), a market operated by the London Stock Exchange. Collins Stewart is acting as nominated adviser and broker to the Company. Highlights * The Company has raised #15.26 million (US$26.94 million), (net of expenses) through a placing of 13,461,756 New Common Shares (the "Placing") at a price of 125 pence per share (the "Placing Price"). * Based on the Placing Price of 125 pence per share and 67,852,691 Common Shares in issue, on Admission Spacelabs will have a market capitalisation of #84.8 million, (US$149.7 million). * The Common shares will be listed on AIM under the symbol SLAB. Deepak Chopra, Chief Executive Officer of Spacelabs Healthcare Inc, said: "We are delighted to have successfully completed the listing of Spacelabs Healthcare on AIM in London. During a period of difficult market conditions we are pleased to have been able to attract a high quality institutional shareholder base. | ![]() currypasty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions